Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSXV: TELO; OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease through the analysis of telomeres, today announced that it will present at the OTCQB Venture Virtual Investor Conference on August 7th, 2025. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. Telo Genomics will be represented by Guido Baechler, Exe ...